When the concentrations of glucose and free fatty acids in the blood of a MetS patient are increased, they can stimulate the binding of NF-κB to the circulating fetuin-A promoter, and then activate the expression of circulating fetuin-A mRNA to further promote circulating fetuin-A protein synthesis and secretion [20]. The gene discussed is NFKB1; the disease is metabolic syndrome.